Cochlear Implants and Auditory Brainstem Implants | AETNA Coverage Update

TL;DR: Aetna, a CVS Health company, modified CPB 0013 governing cochlear implant and auditory brainstem implant coverage, with an effective date of March 7, 2026. Here's what billing teams need to know before submitting claims.

Aetna's cochlear implant coverage policy under CPB 0013 has been updated. This policy covers medical necessity criteria, prior authorization requirements, and reimbursement rules for cochlear implants and auditory brainstem implants. The policy document does not list specific CPT or HCPCS codes in the data provided — pull the full policy text at CPB 0013 Aetna to confirm the exact codes that apply to your billing setup before March 7, 2026.

Quick-Reference Table

Aetna Cochlear Implant Coverage Criteria and Medical Necessity Requirements 2026

The real issue with CPB 0013 is that cochlear implant and auditory brainstem implant billing sits at the intersection of high-cost surgical procedures, strict audiological criteria, and prior authorization requirements that Aetna takes seriously. A documentation gap on medical necessity is the fastest path to a claim denial on these cases — and these are not small-dollar claims.

Aetna's cochlear implant coverage policy has historically required members to meet specific audiological thresholds before the payer considers the procedure medically necessary. That typically means documented severe-to-profound sensorineural hearing loss, failed trials with hearing aids, and formal audiological evaluation. The March 7, 2026 modification to CPB 0013 signals a review of those criteria — and any time Aetna touches this policy, you need to re-verify what your clinical teams are documenting before cases go to the OR.

Prior authorization is standard for cochlear implant procedures under Aetna. That hasn't changed. What billing teams need to watch is whether the updated criteria shift the documentation burden — for example, whether the required trial periods, test score thresholds, or age-specific criteria for pediatric patients have been adjusted.

Auditory brainstem implants are a different animal from cochlear implants. They're indicated for patients who can't benefit from cochlear implants — typically due to absent or non-functional auditory nerves, often in the context of neurofibromatosis type 2. Aetna's coverage policy has historically treated these with more scrutiny than cochlear implants, and reimbursement for these cases depends heavily on whether the clinical documentation matches the updated criteria in CPB 0013.

If your practice handles both device types, don't assume the criteria are the same. Review CPB 0013 separately for cochlear implants and auditory brainstem implants. The coverage policy distinguishes between them, and your billing team should too.

Aetna Cochlear Implant and Auditory Brainstem Implant Exclusions and Non-Covered Indications

Aetna has historically designated certain cochlear implant and auditory brainstem implant indications as experimental or investigational. The specific language in CPB 0013 governs what falls outside covered territory.

Generally, candidates who don't meet audiological eligibility thresholds — or who haven't completed a required hearing aid trial — face coverage denial. Unilateral cochlear implantation in patients with only mild-to-moderate hearing loss has not met Aetna's medical necessity bar historically. Bilateral simultaneous cochlear implantation has also faced scrutiny, with coverage depending on specific plan terms.

Auditory brainstem implants for indications outside of neurofibromatosis type 2 or absent auditory nerve conditions have typically been treated as experimental by Aetna. If your team is billing for an auditory brainstem implant outside that narrow clinical population, expect a hard look from Aetna — and prepare your clinical documentation accordingly.

Any procedure billed for a member whose plan excludes cochlear or auditory implant coverage entirely is a guaranteed denial. Verify plan-level benefits before surgery, not after. That step alone prevents the most avoidable claim denials on these cases.

Coverage Indications at a Glance

The policy data provided does not include a code-level breakdown of indications. The table below reflects what Aetna's CPB 0013 coverage policy has historically addressed. Confirm exact current criteria in the updated March 7, 2026 policy document before billing.

Aetna Cochlear Implant Billing Guidelines and Action Items 2026

CPT, HCPCS, and ICD-10 Codes for Cochlear Implants and Auditory Brainstem Implants Under CPB 0013

The policy data provided for this update does not include specific CPT, HCPCS, or ICD-10 codes. This is not unusual for a CPB modification — Aetna's clinical policy bulletins reference codes that can be embedded in supporting documents or linked fee schedules rather than listed in the primary bulletin.

Do not guess at codes for cochlear implant billing. Using incorrect procedure codes on high-cost surgical claims creates both denial risk and potential compliance exposure.

How to Get the Correct Codes

Access the full CPB 0013 document directly at https://app.payerpolicy.org/p/aetna/0013. The complete policy text includes the applicable code lists. Your payer contract or Aetna's online provider portal is the second source to check — the fee schedule attached to your contract will show which codes Aetna maps to this policy.

Common Code Families to Verify Against CPB 0013

While this post cannot list specific codes without confirmed policy data, cochlear implant and auditory brainstem implant billing typically involves surgical implantation codes, device/supply codes, and audiological evaluation codes. Confirm each of these categories against the updated CPB 0013 text. If your charge capture includes codes you've been using for years, verify they still map correctly to the modified policy — payer modifications sometimes add or remove codes from the covered list.